.4-1.8) were more likely to be susceptible. The second dose of MMR vaccine was received by 57.2% (718/1256) of rubella-susceptible women, with the highest proportion being immigrant women compared with women born in Spain. After vaccination, all women showed rubella immunity.
Elimination of congenital rubella syndrome depends not only on effective childhood immunization but also on the identification and immunization of rubella susceptible women. We assessed rubella susceptibility among pregnant women and evaluated the adherence and response to postpartum immunization with measles, mumps and rubella (MMR) vaccine.
Methods:
Cross-sectional study of women who gave birth at the Hospital Clinic de Barcelona (Spain) between January 2008 and December 2013. Antenatal serological screening for rubella was performed in all women during pregnancy.
In rubella-susceptible women, two doses of MMR vaccine were recommended following birth. We evaluated rubella serological response to MMR vaccination in mothers who complied with the recommendations.
Results:
A total of 22,681 pregnant women were included in the study. The mean age was 32.3 years (SD 5.6), and 73.6% were primipara. The proportion of immigrants ranged from 43.4% in 2010 to 38.5% in 2012. The proportion of women susceptible to rubella was 5.9% (1328). Susceptibility to rubella declined with increasing maternal age. Immigrant pregnant women were more susceptible to rubella (7.6%) than women born in Spain (4.6%). Multivariate analyses showed that younger age (≤ 19 years) aOR 1.7 (95% CI 1.1-2.5), primiparas aOR 1.3 (95% CI 1.1-1.5) and immigrant women aOR 1.6 (95% CI 
Main text

Introduction
Rubella infection occurring just before conception and during early pregnancy may result in miscarriage, fetal death, or congenital defects known as congenital rubella syndrome (CRS) [1] [2] [3] [4] . The extent of the involvement depends on the time of pregnancy at which infection occurs. The highest risk of CRS is found in countries with high rates of rubella susceptibility among women of childbearing age [2] .
In 1998, the World Health Organization (WHO) European Region approved the aims of eliminating indigenous measles and rubella, and controlling congenital rubella [2, 5, 6] . The most important strategy for preventing rubella is immunization of susceptible individuals. However, individuals may be immunized by past vaccination or natural infection [2] . The effectiveness of the rubella vaccine has been demonstrated by the elimination of rubella and CRS from the Region of the Americas [2, 7] . The aim of interrupting the endemic transmission of measles and rubella in Europe in 2015 will only be achieved with a high coverage of vaccination (> 95% with two doses of measles, mumps and rubella (MMR) vaccine) in all geographical areas and all population groups, together with a high-quality surveillance system [8].
Post-delivery vaccination strategies should include MMR vaccination in women susceptible to these diseases. In susceptible pregnant women, immunization with this live attenuated vaccine should be administrated during the postpartum period [2, 9, 10] . In Spain, rubella is a notifiable disease and is monitored through the Spanish Surveillance System [11] . Reported cases of rubella in 2012 were the highest since 2008 (64 confirmed cases: 0.14 cases per 100,000 inhabitants) and most cases occurred in unvaccinated adolescents and young adults. In the 2008-2012 period, 4 rubella outbreaks and 3 cases of CRS have been recorded in immigrants from countries where the rubella vaccine is not routinely administered in childhood [8] . Although the viral circulation of rubella in Spain is supposedly low, it is important to monitor rubella susceptibility, especially in immigrant women, given the observed increase in the immigrant population in recent years, with Spain being one of the main receptor countries in the European Union [12] . In Catalonia, the region where this study was conducted, all pregnant women are screened for rubella antibodies in the first antenatal blood test [11, 13] .
The objectives of this study were to assess rubella susceptibility in the antenatal rubella serology screening; to identify factors associated with susceptible women and to evaluate the adherence and the immunological response to postpartum immunization strategy with MMR vaccine in rubella susceptible women.
Materials and Methods
Study characteristics
We made a cross-sectional study of women who gave birth at the Hospital Clinic of Barcelona (HCB) between January 2008 and December 2013. 
Rubella immunization practices
In Catalonia, an autonomous region in the northeast of Spain with nearly 7.5 million inhabitants, rubella-containing vaccine was introduced into the routine immunization schedule in 1978 for all girls aged 11 years (women born after 1967) [14] . In 1980, in order to improve measles control, the MMR vaccine was introduced in children aged 15 months. In 1987, the MMR replaced the rubella vaccine at 11 years of age. In 1998, the age of administration of the second MMR dose was advanced from 11 to 4 years. Finally, in 2008, it was recommended that the age of administration of the first dose of MMR should be changed from 15 to 12 months [15] . Similar schedules for rubella-containing vaccine have been introduced in other Spanish regions [8] .
Laboratory methods
Following the recommendations of the Department of Health of Catalonia, serological screening for rubella was made in all pregnant women during their first blood test, which is usually made during the first trimester of pregnancy [13] . Levels of rubella IgG antibodies were determined using the ADVIA® Centaur G™ Rubella Assay (Siemens Healthcare Diagnostics Inc.). The immune status was determined using the following cut-off values: <15.0 IU/ml (Susceptible), ≥15 IU/ml (Immune). According to the manufacturer, the sensitivity and specificity of the method are 97.2% and 99.5%, respectively. The intra-assay and inter-assay coefficients are less than 5% and 6.1%, respectively. All samples were analyzed at the HCB microbiology laboratory. 
Collection of variables
Variables were limited to information recorded in the medical records, including maternal date of birth, country of birth, parity, delivery date, date of administration of first and second dose of MMR vaccine, and date of postvaccination blood sample. All women not born in Spain were considered immigrants. Rubella antibody levels during pregnancy were established as the main endpoint and adherence to the second MMR dose and post-vaccination rubella response as the secondary endpoints. We merged data extracts from medical information systems from Maternal-Fetal Medicine department and the AVC. In the univariate analysis, absolute frequencies and percentages were used to describe categorical variables and means and standard deviation (SD) or 95% confidence intervals (CI) to describe quantitative variables with a normal distribution, and medians and interquartile range otherwise. We calculated the proportion of women susceptible to rubella with the odds ratios (OR) and 95% CI. To determine variables independently associated with rubella susceptibility and adherence to MMR immunization, the crude odds ratios were calculated for different variables. For each variable studied, we took the group with the lowest rubella susceptibility as the reference group. Odds ratios were adjusted using multiple logistic regression analysis. The statistical analysis was performed using the STATA ® statistical package v12.1. Statistical significance was established as <0.05.
Statistical Analysis
Ethical considerations
The study investigators followed the principles of the Declaration of Helsinki. Table 1 .
Results
Characteristics of the study population
Factors associated with susceptibility to rubella
During the study period, 87.9 % (19,925), 11.5% (2,601) and 0.7% (148) of pregnant women had one, two or three rubella serology tests, respectively (corresponding to different pregnancies). Of the 1,328 susceptible women, 46%
(611) were born in Spain, 9.6% (128) in China, 5.7% (76) in Morocco, and 4.4% (58) in the Philippines. Total susceptibility to rubella was 5.9% (1,328). There was a variation in susceptibility by year, ranging from 3.6% in 2008 to 7.6% in 2011 (p <0.001) (Figure 1) . The highest susceptibility rate was in the <20 years age group, with an overall susceptibility of 8%. Susceptibility to rubella declined with increasing maternal age, with women aged ≥40 years having the lowest susceptibility (4.4%). Immigrant women had higher susceptibility (7.6%) than pregnant women born in Spain (4.6%), OR 1.7 (95% CI 1.5-1.9). Table 2 and 3: univariate and multivariate analyses showed that the age group, parity, and the region of birth were independently associated with the prevalence of rubella antibodies. Women were more likely to be susceptible if they were younger (≤ 19 years, aOR 1.7 (95% CI 1.1-2.5)), primiparas aOR 1.3 (95% CI 1.1-1.5) or not born in Spain aOR 1.6 (95% CI 1.4-1.8). A total of 94.6% (1256/1328) of women susceptible to rubella received the first dose of MMR vaccine. 
Factors associated with adherence to the second dose of MMR vaccine
Immunological response to two doses of MMR vaccine.
Around 60% (429/718) of women who received the second MMR dose returned for the assessment of the antibody response. After the two doses of MMR, all women showed protective antibody titers (≥15 IU/ml) against rubella.
Discussion
To our knowledge this is the largest study assessing rubella susceptibility among pregnant women in Spain, and the only one evaluating vaccine adherence and immunological response to the second MMR dose in the postpartum period. Our results showed that overall rubella susceptibility among 22,681 pregnant women between 2008 and 2013 was 5.9%, and was 7.6% in [17, 18] .
Previous Spanish studies have reported rubella antibody prevalence ranging from 88.3% to 94.8% [15, [19] [20] [21] [22] , and our results are within this range (94.1%).
Recent studies in other European countries reported similar data: the prevalence observed in Norway was 94.4% [23] and in England between 94.9% [24] and 97.4% [25] . In the United States, the prevalence was 91.5% [26] , while in Canada the prevalence was 93.2% in Canadian-born mothers but was lower in immigrants from Northern Africa, the Middle East, China and the South Pacific [27] .
In recent years, the incidence of rubella has been very low in Spain, with limited outbreaks among immigrants from Eastern European countries [8, 14, [28] [29] [30] . As a consequence, the lack of natural boosting due to an absence of circulating virus may result in higher susceptibility, particularly among younger women [31] .
Higher susceptibility may also reflect a decline in the antibody levels from childhood vaccinations, as this cohort would have been eligible for two doses of rubella-containing vaccine, although data from surveillance of rubella and CRS suggest that waning immunity with increased susceptibility to rubella does not occur [10, 25, 32, 33] . In 2012, Spanish national coverage of the first dose of MMR vaccine in infants was > 95%, but only 90% for the second dose [34] . Women aged ≥40 years, who were born before the introduction of the rubella vaccination program in 1967, had a significantly-lower susceptibility to rubella than those born later. The significant increase in immunity with increasing maternal age (p<0.001) may be attributable to an increase in past exposure to natural infection, and to greater opportunities for immunization in the childbearing years, either as a result of pre-conception screening or in the postpartum period. Women in older age groups are also more likely to be multipara and therefore to have been offered postpartum vaccination.
Increased travel to and from countries with circulating rubella, combined with social interaction with populations presenting lower levels of rubella-specific antibodies, may give rise to local outbreaks when protection falls below 90% [25, 35] . In the present study, immigrant pregnant women presented greater susceptibility to rubella (7.6%) compared to those born in Spain (4.6%). These findings were also observed in other Western European countries [19, 20, 36] . It is reported that the African and South-East Asian regions have the highest estimated number of CRS cases and also have the lowest uptake of the vaccine [2] . In our study, women born in Asia had the greatest susceptibility (10.8%) to rubella. Similar results were observed in other Spanish studies where susceptibility in Asian women was 7.7% [22] and 10.4% [36] , respectively.
Many hospitals have adopted standing orders for women not immune to rubella: post-partum standing orders have been shown to be effective in increasing rubella immunization among non-immune women, prior to hospital discharge [31] . We found good acceptance from susceptible women although adherence to the second dose was less than 55%. One reason for this may be that it is difficult to motivate adults to be vaccinated, particularly when there are no outbreaks [37] . Language barriers may also affect adherence, but this was not the case in our study, as immigrant women from Asia had greater adherence. We observed an increase in adherence over the study period from 41.1% (2008) 
